holding patiently, page-2

Dear starpepper

Many thanks for your support, and recent post. It will be worth the wait!

A few quick things to answer your questions:

1. sales pipeline is developing and in process of being converted into commercial sales over the coming months....stay tuned. It does not happen overnight, need to build trust, relationships for long-term customers for orders and recurring revenue. Now we have the full commercial product suite, with some exciting new products (the cassette, Blue-Diligence(TM), etc), and people to sell and market our products, including Micronic America who are gaining traction as our distributors for USA and Canada, we have put ourselves in a strong position to convert sales after all this time. We trust that once the market can see traction on the sales front via announcements, Appendix 4C Cash Flow Reports, half-yearly and annual financials, we will get good buying support coming into the stock which is a lot of people's radars.

2. Competition - our main competition is the barcode (limitations can't read in frost so have to handle each sample, can't sense temperature). There are a few companies working with RFID technology which is a superb technology in certain environments, but generally not in -80degC down to -196degC (liquid nitrogen). Please note that the Icebreaker cryovial by Sysmex Bioscience uses RFID and "may" survive down to -196degC (no guarantees) but not operate - VERY expensive. Competition is healthy and proves there is a market!!!

3. Other market applications - we too can't wait to look at further applications within healthcare as well as outside of healthcare - security and defence, aerospace and aviation, industrial and manufacturing, cold-chain/supply chain/logistics. Key till now has been "laser focus" on initial market of biobanking, but when we start to gain traction there, the company and its team can not wait to explore these other opportunities (take the blinkers off) and look at commercial opportunities, licensing opportunities, to create further value for the shareholders of the "platform technology".

Thanks again for your support.

Regards